-
Industry, Univ Labs Partner on Cannabinoid Pain Drug
A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis.
-
Simpler Method Devised to Validate Covid-19 Tests
An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19.
-
Crispr Edits Out HIV-Like Genes from Monkey DNA
Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies.
-
Univ, Industry Labs Study Inhaled Covid-19 Antibodies
Researchers at University of Pennsylvania and Regeneron are studying delivery of synthetic antibodies directly to the nose to prevent Covid-19 infections.
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Infographic – Public Favors Rejoining Paris Accord
A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agreement.
-
Trial Requested for Covid-19 Vaccine Nasal Spray
Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine.
-
Wheat Genome Study IDs Critical Genes, Traits
An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival.
-
Building Credibility as a Budding Developer
As businesses continue to evolve, it is clear that credibility is becoming a reliable component to retain your customer base.
-
Trial Underway Testing Insulin Capsules
Researchers began screening participants for a clinical trial assessing insulin formulated as capsules for people with type 2 diabetes.